Biogen buys UK gene therapy firm Nightstar for $800mBiogen has agreed to buy UK-based gene therapy biotech Nightstar, which focuses on using modified viruses as therapies Share XBiogen buys UK gene therapy firm Nightstar for $800mhttps://pharmaphorum.com/news/biogen-buys-uk-gene-therapy-firm-nightstar-for-800m/
